Lahham Aroub, Holland Anne E
Department of Immunology and Pathology, Monash University, Melbourne 3800, Australia.
Institute for Breathing and Sleep, Melbourne 3084, Australia.
Life (Basel). 2021 Nov 15;11(11):1236. doi: 10.3390/life11111236.
Pulmonary rehabilitation is a strongly recommended and effective treatment for people with chronic lung disease. However, access to pulmonary rehabilitation is poor. Globally, pulmonary rehabilitation is accessed by less than 3% of people with chronic lung disease. Barriers to referral, uptake and completion of pulmonary rehabilitation are well documented and linked with organizational, practitioner and patient-related factors. Enhancing the knowledge of health care professionals, family carers, and people with chronic lung disease about the program and its benefits produces modest increases in referral and uptake rates, but evidence of the sustainability of such approaches is limited. Additionally, initiatives focusing on addressing organizational barriers to access, such as expanding services and implementing alternative models to the conventional center-based setting, are not yet widely used in clinical practice. The COVID-19 pandemic has highlighted the urgent need for health care systems to deliver pulmonary rehabilitation programs remotely, safely, and efficiently. This paper will discuss the pressing need to address the issue of the low accessibility of pulmonary rehabilitation. It will also highlight the distinctive challenges to pulmonary rehabilitation delivery in rural and remote regions, as well as low-income countries.
肺康复是对慢性肺病患者强烈推荐且有效的治疗方法。然而,肺康复的可及性较差。在全球范围内,不到3%的慢性肺病患者能够接受肺康复治疗。肺康复转诊、接受和完成方面的障碍已有充分记录,且与组织、从业者和患者相关因素有关。提高医疗保健专业人员、家庭护理人员和慢性肺病患者对该项目及其益处的认识,会使转诊率和接受率略有提高,但此类方法可持续性的证据有限。此外,专注于解决获取方面组织障碍的举措,如扩大服务范围和实施替代传统中心式设置的模式,在临床实践中尚未得到广泛应用。新冠疫情凸显了医疗保健系统迫切需要以远程、安全和高效的方式提供肺康复项目。本文将讨论解决肺康复可及性低这一问题的迫切需求。它还将强调农村和偏远地区以及低收入国家在提供肺康复方面面临的独特挑战。